β¨ Medicines Classification
7 SEPTEMBER NEW ZEALAND GAZETTE 3003
Carbaryl; in medicines for external use, containing 2% or less of carbaryl
Cabenzolone; and its salts; compounds of carbenoxolone; in medicines for external use
Cardamom; compound tincture; aromatic tincture
Catechu
Cholecalciferol; in medicines containing 25 micrograms or less per recommended daily dose
Choline salicylate
Chlorhexidine
Chlorphenesin
Chymotrypsin
Cinchocaine; for external use in medicines containing 2% or less
Clioquinol; in medicines for external use
Contact lens solutions
Crocus sativus; extracts of
Crotamiton
2,4-Dichlorobenzyl alcohol
Dequalinium; and its salts
Dibromopropamidine isethionate; except for ophthalmological use
Diethylamine salicylate
Di-iodohydroxyquinoline; in medicines for external use
Dimenhydrinate; and its salts; in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane
Dioctyl sodium sulphosuccinate
Diphemanil; and its salts
Edetic acid; in medicines containing 0.25% or less
Ethyl nicotinate
Ethyl salicylate
Fenticlor; in medicines for external use
Fibrinolysin; in medicines for external use
Folic acid; in medicines containing 500 mcg or less per recommended daily dose
Galactose
Gentian compound concentrated infusion
Glycol salicylate
Guaiphenesin; in medicines containing 2% or less of guaiphenesin
8-Hydroxyquinoline; and its halogenated and alkyl derivatives and their salts; in medicines for external but not vaginal use
Haloprogin
Halquinol; in medicines for external use
Heparins; in medicines for external use
Hexetidine; in medicines for external but not vaginal use
Hexyl nicotinate
Histamine acid phosphate; in medicines containing 0.5% or less of histamine acid phosphate
Hyaluronidase; for external use
Hydroxocobalamin; in medicines containing 50 mcg or less of hydroxocobalamin per recommended daily dose
Intrinsic factor
Iodine; in medicines for external use
Iodoform
Lignocaine; and its salts; in medicines for external use containing 2% or less of lignocaine and in throat lozenges containing 30 milligrams or less per dose form
Malathion; in medicines for external use containing 2% or less of malathion
Meclozine; and its salts; in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane
Menthyl valerate
Methyl nicotinate
Nicotinamide; in medicines containing 100 mg or less per dose form
Nicotinic acid; in medicines containing 100 mg or less per dose form
Nicotinyl alcohol; in medicines containing 100 mg or less per dose form
Nonylic acid; and its derivatives
Oxymetazoline; and its salts; for nasal use when sold at an airport
Pancreatin
Paracetamol; in solid dose form for oral use, containing 500 mg or less of paracetamol and in packs containing not more than 10 grams of paracetamol per pack
Pepsin
Permethrin; in medicines containing 1% or less of permethrin
Phenothrin
Phenylephrine; and its salts; in eye preparations containing 0.12% or less of phenylephrine; and in nasal preparations when sold at an airport
Piperonyl butoxide
Polynoxylin
Potassium chloride; in medicines for oral rehydration therapy; for use in haemodialysis concentrates and peritoneal dialysis solutions
Potassium citrate; in medicines for oral rehydration therapy
Potassium guaiacolsulphonate
Pramocaine; for external use in medicines containing 2% or less
Prilocaine; for external use in medicines containing 2% or less
Promethazine theoclate; in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane
Pronase
Propyl undecylenate
Pumilio pine oil
Pyrethrins I and II
Quaternary ammonium antiseptic compounds
Quinine; and its salts; in medicines containing 50 mg or less of quinine per recommended daily dose
Salicylic acid; and its salts; in medicines for external use containing 12.5% or less of salicylic acid
Senega
Sodium bitartrate
Sodium dichloroisocyanurate
Sodium lauryl sulphoacetate
Sodium sulphide
Strontium chloride
Subtilisin A
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1995, No 96
NZLII —
NZ Gazette 1995, No 96
β¨ LLM interpretation of page content
π₯
Classification of Medicines under the Medicines Act 1981
(continued from previous page)
π₯ Health & Social WelfareMedicines Act 1981, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines, General Sale Medicines, Classification